PharmaNutra SpA (IT:PHN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PharmaNutra S.p.A. has signed a distribution agreement with Sigma Lifesciences to market its SiderAL® and Ultramag® products in Canada, expanding its presence in North America. The products, which feature the patented Sucrosomial® Technology, are set to launch in the second quarter of 2025. This strategic move aims to capitalize on the significant market potential in Canada.
For further insights into IT:PHN stock, check out TipRanks’ Stock Analysis page.